Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Vomiting
ADR ID BADD_A04623
ADR Hierarchy
07      Gastrointestinal disorders
07.01      Gastrointestinal signs and symptoms
07.01.07      Nausea and vomiting symptoms
07.01.07.003      Vomiting
Description A disorder characterized by the reflexive act of ejecting the contents of the stomach through the mouth. [CTCAE] The forcible expulsion of the contents of the STOMACH through the MOUTH. [MeSH]
MedDRA Code 10047700
MeSH ID D014839; D014839; D014839
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Bilious vomiting | Emesis | Habit vomiting | Hyperemesis | Nausea and vomiting | Nausea vomiting and diarrhea | Nausea vomiting and diarrhoea | Nausea with vomiting | Persistent vomiting | Vomited | Vomiting | Vomiting alone | Vomiting NOS | Vomiting reflex | Vomiting aggravated | Vomiting of medication | Tablet in vomitus | Vomiting post chemotherapy | Vomiting post radiotherapy | Blennemesis | Postprandial emesis
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
5-hydroxytryptamine receptor 3AP46098T64591
Broad substrate specificity ATP-binding cassette transporter ABCG2Q9UNQ0T56556
CatalaseP04040T01597
CholinesteraseP06276T99799
Dihydropyrimidine dehydrogenase [NADP(+)]Q12882T75890
Superoxide dismutase [Cu-Zn]P00441T22977
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02493Selinexor0.000533%
BADD_D02495Duvelisib0.000799%
BADD_D02496Elagolix--
BADD_D02497Avatrombopag0.003267%
BADD_D02498Abemaciclib0.013853%
BADD_D02500Alpelisib0.008259%
BADD_D02503Telotristat ethyl-
BADD_D02504Lorlatinib--
BADD_D02507Deutetrabenazine0.009150%
BADD_D02508Edaravone--
BADD_D02509Brigatinib0.002131%
BADD_D02510Rucaparib0.068201%
BADD_D02511Siponimod--
BADD_D02512Secnidazole0.004823%
BADD_D02513Pegvaliase0.032041%
BADD_D02514Etelcalcetide0.086741%
BADD_D02515Pexidartinib0.001332%
BADD_D02517Enasidenib--
BADD_D02518Semaglutide0.079342%
BADD_D02520Baloxavir marboxil0.023146%
BADD_D02522Lithium citrate-
BADD_D02524Ivosidenib0.001066%
BADD_D02526Larotrectinib0.000799%
The 62th Page    First    Pre   62    Total 62 Pages